We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
3 Top-Ranked Leading Healthcare Funds Built for Market Defense
Read MoreHide Full Article
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services remains relatively stable, regardless of market conditions. Among the sector players, many pharmaceutical companies also pay out regular dividends.
Companies that consistently offer dividends are financially stable and generate a steady cash flow, irrespective of market conditions. Mutual funds are the perfect choice for investors seeking to enter this sector, as they have the advantages of broad diversification and analytical insight.
Fidelity Advisor Biotechnology Fund invests most of its net assets in common stocks of foreign and domestic companies that are principally engaged in the research, development, manufacture and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. FBTIX advisors choose to invest in stocks based on fundamental analysis factors such as the issuer's financial condition, industry position, as well as market and economic conditions.
Fidelity Advisor Biotechnology Fund has five-year annualized returns of 25%. As of the end of April 2026, FBTIX held 89 issues, with 14.8% of its assets invested in ABBVIE.
PGIM Jennison Health Sciences Fund seeks capital appreciation over time by investing most of its net assets in equity and equity-related securities of companies within the health sciences sector, such as pharmaceutical companies, biotechnology companies, medical device manufacturers, healthcare service providers and health maintenance organizations. PHLAX generally chooses to invest in companies that derive at least 50% of their assets, revenues or profits from operations in the healthcare sector.
PGIM Jennison Health Sciences Fund has three-year annualized returns of 14.1%. PHLAX has an expense ratio of 1.15%.
BlackRock Health Sciences Opportunities Portfolio Fund invests most of its net assets in equity securities, primarily common stock, of domestic and foreign companies in health sciences and related industries. SHSAX advisors generally invest in companies that concentrate in healthcare equipment and supplies, healthcare providers and services, biotechnology, and pharmaceuticals.
BlackRock Health Sciences Opportunities Portfolio Fund has three-year annualized returns of 8.8%. Erin Xie has been the fund manager of SHSAX since July 2003.
View the Zacks #1 Rank List
Image: Bigstock
3 Top-Ranked Leading Healthcare Funds Built for Market Defense
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services remains relatively stable, regardless of market conditions. Among the sector players, many pharmaceutical companies also pay out regular dividends.
Companies that consistently offer dividends are financially stable and generate a steady cash flow, irrespective of market conditions. Mutual funds are the perfect choice for investors seeking to enter this sector, as they have the advantages of broad diversification and analytical insight.
Below, we share with you three healthcare mutual funds, namely Fidelity Advisor Biotechnology Fund (FBTIX - Free Report) , PGIM Jennison Health Sciences Fund (PHLAX - Free Report) and BlackRock Health Sciences Opportunities Portfolio Fund (SHSAX - Free Report) . Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of funds.
Fidelity Advisor Biotechnology Fund invests most of its net assets in common stocks of foreign and domestic companies that are principally engaged in the research, development, manufacture and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. FBTIX advisors choose to invest in stocks based on fundamental analysis factors such as the issuer's financial condition, industry position, as well as market and economic conditions.
Fidelity Advisor Biotechnology Fund has five-year annualized returns of 25%. As of the end of April 2026, FBTIX held 89 issues, with 14.8% of its assets invested in ABBVIE.
PGIM Jennison Health Sciences Fund seeks capital appreciation over time by investing most of its net assets in equity and equity-related securities of companies within the health sciences sector, such as pharmaceutical companies, biotechnology companies, medical device manufacturers, healthcare service providers and health maintenance organizations. PHLAX generally chooses to invest in companies that derive at least 50% of their assets, revenues or profits from operations in the healthcare sector.
PGIM Jennison Health Sciences Fund has three-year annualized returns of 14.1%. PHLAX has an expense ratio of 1.15%.
BlackRock Health Sciences Opportunities Portfolio Fund invests most of its net assets in equity securities, primarily common stock, of domestic and foreign companies in health sciences and related industries. SHSAX advisors generally invest in companies that concentrate in healthcare equipment and supplies, healthcare providers and services, biotechnology, and pharmaceuticals.
BlackRock Health Sciences Opportunities Portfolio Fund has three-year annualized returns of 8.8%. Erin Xie has been the fund manager of SHSAX since July 2003.
To view the Zacks Rank and the past performance of all healthcare mutual funds, investors can click here to see the complete list of healthcare mutual funds.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>